COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,160 Articles (22,703 medRxiv, 8,457 bioRxiv)

Most recent first Previous |  Page 1084: Articles 10831-10840  | Next

A kinetic model considering the decline of antibody level and vaccination of COVID-19
XU, C. q., Huang, X., Zhang, Z., Cui, J.
10.1101/2021.12.01.21266680 — Posted: 2021-12-05
A randomized clinical trial to stimulate the cholinergic anti-inflammatory pathway in patients with moderate COVID-19-pneumonia using a slow-paced breathing technique
Balint, E. M., Gruener, B., Haase, S., Kaw-Geppert, M., Thayer, J. F., Guendel, H. O., Jarczok, M. N.
10.1101/2021.12.03.21266946 — Posted: 2021-12-05
Using an electronic frailty index to predict adverse outcomes in geriatric COVID-19 patients: data from the Stockholm GeroCovid study
Mak, J. K. L., Eriksdotter, M., Annetorp, M., Kuja-Halkola, R., Kananen, L., Bostrom, A.-M., Kivipelto, M., Metzner, C., Back Jerlardtz, V., Engstrom, M., Johnson, P., Lundberg, L. G., Akesson, E., Suhl Oberg, C., Olsson, M., Cederholm, T., Hagg, S., Religa, D., Jylhava, J.
10.1101/2021.12.03.21267254 — Posted: 2021-12-05
Protection and waning of natural and hybrid COVID-19 immunity
Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., Milo, R.
10.1101/2021.12.04.21267114 — Posted: 2021-12-05 Discussion: Onsite
Estimating area-level variation in SARS-CoV-2 infection fatality ratios
Ladau, J., Kuo, C., Brodie, E. L., Falco, N., Bansal, I., Hoffman, E. B., Joachimiak, M. P., Mora, A. M., Walker, A. M., Wainwright, H. M., Wu, Y., Jacobson, D., Hess, M., Brown, J. B., Abuabara, K.
10.1101/2021.12.04.21267288 — Posted: 2021-12-05
Persistent Symptoms Among Frontline Health Workers Post-acute COVID-19 Infection
WOSE KINGE, C., HANEKOM, S., LUPTON-SMITH, A., AKPAN, F., MOTHIBI, E., MAOTOE, T., LEBATIE, F., MAJUBA, P., SANNE, I., CHASELA, C.
10.1101/2021.12.03.21267225 — Posted: 2021-12-05
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia
Klink, G. V., Safina, K. R., Nabieva, E., Shvyrev, N., Garushyants, S., Alekseeva, E. I., Komissarov, A. B., Danilenko, D. M., Pochtovyy, A. A., Divisenko, E. V., Vasilchenko, L. A., Shidlovskaya, E. V., Kuznetsova, N. A., The Coronavirus Russian Genetics Initiative (CoRGI) Consortium, , Samoilov, A. E., Neverov, A., Popova, A., Fedonin, G., The CRIE Consortium, , Akimkin, V. G., Lioznov, D., Gushchin, V., Shchur, V., Bazykin, G. A.
10.1101/2021.12.02.21267168 — Posted: 2021-12-05
Impact of individual-level characteristics and transmission mitigation behaviors on SARS-CoV-2 infection and seroprevalence in a large Northern California Bay Area cohort
Adams, C., Horton, M., Solomon, O., Wong, M., Wu, S. L., Fuller, S., Shao, X., Fedrigo, I., Quach, H., Quach, D., Meas, M., Lopez, L., Broughton, A., Barcellos, A. L., Shim, J., Seymens, Y., Hernandez, S., Montoya, M., Johnson, D. M., Beckman, K., Busch, M. P., Coloma, J., Lewnard, J., Harris, E., Barcellos, L. F.
10.1101/2021.12.02.21266871 — Posted: 2021-12-05 Discussion: Onsite
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
Mohanraj, D., Baldwin, S., Singh, S., Gordon, A., Whitelegg, A.
10.1101/2021.12.03.21267250 — Posted: 2021-12-05 Discussion: Onsite
Underlying co morbidity reveals unique immune signatures in Type II diabetes patients infected with SARS-CoV2
Sengupta, S., Bhattacharya, G., Chatterjee, S., Datey, A., Shaw, S. K., Suranjika, S., Nath, P., Barik, P. K., Prasad, P., PARIDA, A., Chattopadhyay, S., Swain, R. K., DEVADAS, S.
10.1101/2021.12.03.21267282 — Posted: 2021-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).